Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Nearly 200 cases of pediatric hepatitis have now been reported in more than a dozen countries and several states.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
While vaccination typically provides robust protection against severe disease, they’re less effective for immunocompromised people.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
Boosters reduced the risk of hospitalization and death by about 80% for people with HIV, cancer, autoimmune conditions or organ transplants.
Organ transplant recipients take immunosuppressive drugs that impair immune response to pathogens and vaccines.
Experts recommend no more than two drinks for men or one drink for women per day.
Fatty liver disease dominated the Hep science news this year, but COVID-19 remains a concern for people with liver disease.
The drug, which blocks entry of HBV into liver cells, also prevents HDV replication.
People with fatty liver disease and obesity who underwent bariatric surgery had better clinical outcomes.
Heavy alcohol use during the pandemic was linked to a rise in waiting list registrations and transplants due to alcohol-related hepatitis.
Even with this increase, older individuals now have better transplant outcomes.
Older and immunocompromised people and those with underlying health conditions could benefit most from additional shots.
Boosters further reduce the risk of severe illness and can help curb coronavirus transmission.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.